PhaseV, a leader in AI/ML for clinical development, today announced it has received three significant 2025 industry honors, highlighting the growing market traction and adoption of its platform for ...

Tivic Health® Systems, Inc. , a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and webcast on Friday, ...

Positive Regulatory Response Marks Important Milestone for NS002 Development ProgramTEL AVIV, Nov. 06, 2025 (GLOBE NEWSWIRE) ...

Get the latest on Pulse Biosciences’ Q3 2025 earnings: commercial growth, FDA progress, and clinical trial updates in soft tissue and cardiac therapies.

"Omada is preparing for the next era of obesity care - one with broader access to GLP-1 medications of various types and price points," said Sean Duffy, CEO and Co-Founder of Omada Health. "The White ...

Health Food Symmetry (HFS) undertakes a $2 million funding round ahead of a planned public listing in the next 12 to 18 ...

Earflo, a medical technology company developing a non-invasive, at-home treatment for negative middle ear pressure in ...

Nasus Pharma (NSRX) announced that it recently received a No-Objection Letter from Health Canada, the country’s primary regulatory authority for ...

UHN joins Helix's leading group of partner health systems in the Helix Research Network, the largest and fastest growing ...

A new report examining Bexar County’s health landscape suggests instabilities and active work to address inequities spurred, ...

Bringing together advanced spine surgery technology and its skilled team of surgical experts, Adena Health now offers patients a more convenient option for their spinal care.

As drug development enters a new era, Certara is expanding its global team of scientists and technologists to lead the shift toward AI-powered testing methods.